Bioventus (BVS) News
NASDAQ: BVSHealth CareMedical/Dental InstrumentsUSD
9.88-0.07 (-0.70%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
BVS news summary
We found 6 recent headlines mentioning Bioventus (BVS): 0 in the past week and 6 in the past 30 days, most often from Nasdaq, Seeking Alpha, GlobeNewswire. For price context, BVS is down 0.70% at $9.88. The most recent story, "Bioventus Reports Higher Q3 Profit, Cuts 2026 Sales Outlook; Stock Down", was published by Nasdaq on Nov 3, 2026.
Headlines link to the original publishers. MetaCap does not republish third-party articles.
Summary generated from market data by MetaCap's automated system. Methodology
Latest Bioventus headlines
- Bioventus Reports Higher Q3 Profit, Cuts 2026 Sales Outlook; Stock Down(RTTNews) - Bioventus Inc. (BVS) reported third-quarter financial results, reflecting revenue growth driven by its pain treatments business. The company also lowered its full-year 2026 sales guidance.NasdaqBVS, UHAL.B
- Bioventus expects 2026 revenue of $590M-$595M while reaffirming adjusted EPS of $0.75-$0.79Seeking Alpha
- Bioventus (BVS) Q3 2026 Earnings Call Transcript@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The MoNasdaq
- Bioventus Non-GAAP EPS of $0.17 beats by $0.01, revenue of $142.4M misses by $7.12MSeeking Alpha
- Bioventus Reports Third Quarter Financial ResultsDURHAM, N.C., Nov. 02, 2026 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, today reported financial results for…GlobeNewswire
- Bioventus to Report Third Quarter of Fiscal Year 2026 Financial Results on November 2, 2026DURHAM, N.C., Oct. 27, 2026 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, today announced that it will report…GlobeNewswire